|
|
Volumn 6, Issue 1, 2009, Pages 12-13
|
|
Myocardial protection: Is primary PCI enough?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE TRIPHOSPHATE;
ANTICOAGULANT AGENT;
ANTIINFLAMMATORY AGENT;
ANTIOXIDANT;
ANTITHROMBOCYTIC AGENT;
ATRIAL NATRIURETIC FACTOR;
CALCIUM CHANNEL BLOCKING AGENT;
CHOLESTEROL;
CYCLOSPORIN;
GLUCOSE;
INSULIN;
MITOCHONDRIAL PERMEABILITY TRANSITION PORE;
POTASSIUM;
PROTEIN KINASE;
ARTICLE;
CELL DEATH;
CHANNEL GATING;
COMORBIDITY;
DIABETES MELLITUS;
DISEASE MODEL;
ECHOCARDIOGRAPHY;
HEART INFARCTION;
HEART INFARCTION PREVENTION;
HEART INFARCTION SIZE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART MUSCLE CELL;
HEART MUSCLE PERFUSION;
HEART PROTECTION;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
MORBIDITY;
MORTALITY;
NONHUMAN;
OXIDATIVE PHOSPHORYLATION UNCOUPLING;
PERCUTANEOUS CORONARY INTERVENTION;
PRIORITY JOURNAL;
REPERFUSION INJURY;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
ST SEGMENT ELEVATION;
TREATMENT OUTCOME;
VASCULAR PATENCY;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANIMALS;
CARDIOVASCULAR AGENTS;
COMBINED MODALITY THERAPY;
DISEASE MODELS, ANIMAL;
HUMANS;
MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS;
MYOCARDIAL INFARCTION;
MYOCARDIAL REPERFUSION INJURY;
MYOCARDIUM;
PROTEIN KINASES;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
|
|
EID: 58049208264
PISSN: 17434297
EISSN: 17434300
Source Type: Journal
DOI: 10.1038/ncpcardio1371 Document Type: Article |
|
Times cited : (6)
|
|
References (8)
|
